• 1
    National Cancer Institute. SEER. Washington, DC: Department of Health and Human Services, 1998.
  • 2
    Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973–1995: a report card for the U.S. Cancer. 1998; 82: 11971207.
  • 3
    Chevarley F, White E. Recent trends in breast cancer mortality among white and black US women. Am J Public Health. 1997; 87: 775781.
  • 4
    American Cancer Society. Cancer and the poor: a report to the nation. Findings of regional hearings conducted by the American Cancer Society. Washington, DC: American Cancer Society, 1989.
  • 5
    Bassett M, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health. 1986; 76: 14001403.
  • 6
    Lannin DR, Matthews HF, Mitchell J, Swanson MS, Swanson FH, Egan MK. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. J Am Med Assoc. 1998; 279: 18011807.
  • 7
    Hunter CP. Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer. 2000; 88: 11931202.
  • 8
    Krieger N, Sidney S. Racial discrimination and blood pressure: the CARDIA study of young black and white adults. Am J Public Health. 1996; 86: 13701378.
  • 9
    Krieger N. Embodying inequality: a review of concepts, measures, and methods for studying health. Int J Health Serv. 1999; 29: 295352.
  • 10
    Dignam JJ. Difference in breast cancer prognosis among African-American and Caucasian women. CA. 2000; 50: 5064.
  • 11
    Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1991; 91: 14871491.
  • 12
    El-Tamer MB, Homel P, Wait RB. Is race a poor prognostic factor in breast cancer? J Am Coll Surg. 1999; 189: 4145.
  • 13
    McWhorter WP, Mayer WJ. Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health. 1987; 77: 15151517.
  • 14
    Allen C, Cox EB, Manton KG, Cohen HJ. Breast cancer in the elderly: current patterns of care. J Am Geriatr Soc. 1986; 34: 637642.
  • 15
    Chu J, Diehr P, Feigl P, et al. The effect of age on the care of women with breast cancer in community hospitals. J Gerontol. 1987; 42: 185190.
  • 16
    Howard J, Hankey BF, Greenberg RS, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer. 1992; 69: 23492360.
  • 17
    Breen N, Wesley MN, Merrill RM, Johnson K. The relationship of socioeconomic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute black/white cancer survival study. Ethn Dis. 1999; 9: 111125.
  • 18
    Mohla S, Sampson CC, Khan T, Enterline JP, Leffall L Jr., White JE. Estrogen and progesterone receptors in breast cancer in black Americans: correlation of receptor data with tumor differentiation. Cancer. 1982; 50: 552559.
  • 19
    Ownby HE, Frederick J, Russo J, et al. Racial differences in breast cancer patients. J Natl Cancer Inst. 1985; 75: 5560.
  • 20
    Crowe JP Jr., Gordon NH, Hubay CA, Pearson OH, Marshall JS, McGuire WL. The interaction of estrogen receptor status and race in predicting prognosis for stage II breast cancer patients. Surgery. 1986; 100: 599605.
  • 21
    Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994; 86: 705712.
  • 22
    Connor CS, Touijer KA, Krishnan L, Mayo MS. Local recurrence following breast conservation therapy in African-American women with invasive breast cancer. Am J Surg. 2000; 179: 2226.
  • 23
    Trock BJ. Breast cancer in African American women: epidemiology and tumor biology. Breast Cancer Res Treat. 1996; 40: 1124.
  • 24
    Wazer DE. The role of radiation in breast conserving therapy. Obstet Gynecol Clin North Am. 1994; 21: 681691.
  • 25
    Warren JL, Feuer E, Potosky AL, Riley GF, Lynch CF. Use of Medicare hospital and physician data to assess breast cancer incidence. Med Care. 1999; 37: 445456.
  • 26
    Freeman JL, Zhang D, Freeman DH, Goodwin JS. An approach to identifying incident breast cancer cases using Medicare claims data. J Clin Epidemiol. 2000; 53: 605614.
  • 27
    NIH Consensus Conference. Treatment of early breast cancer. J Am Med Assoc 1991; 265: 391395.
  • 28
    Stambler HV. The area resource file — a briefing book. Public Health Rep. 2000; 103: 184186.
  • 29
    Mandelblatt J, Hadley J, Kerner J, et al. Patterns of breast carcinoma treatment in older women: patient preference, clinical, and physician influences. Cancer. 2000; 89: 561573.
  • 30
    Du X, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care. 2000; 387: 719727.
  • 31
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40: 373383.
  • 32
    Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613619.
  • 33
    Newschaffer CJ, Bush TL, Penberthy LE, Bellantoni M, Helzlsour K, Diener-West M. Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol. 1998; 53: M372M378.
  • 34
    Garnick DW, Luft HS, Robinson JC, Tetreault J. Appropriate measures of hospital market areas. Health Serv Res. 1987; 22: 6989.
  • 35
    Phibbs CS, Robinson JC. A variable-radius measure of local hospital market structure. Health Serv Res. 1993; 28: 313324.
  • 36
    Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley, 1981.
  • 37
    STATA reference manual. Release 5. College Station, TX: Stata Press, 1997; 2: 540554.
  • 38
    Zhang J, Yu KF. What's a relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. J Am Med Assoc. 1998; 280: 16901691.
  • 39
    Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992; 326: 11471149.
  • 40
    Lazovich D, White E, Thomas DB, Moe RE. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. J Am Med Assoc. 1991; 266: 34333438.
  • 41
    Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health consensus development conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999; 86: 628637.
  • 42
    Albain KS, Green SR, Lichter AS, et al. Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol. 1996; 14: 30093017.
  • 43
    Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. Cancer. 1997; 79: 314319.
  • 44
    Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000; 92: 269271.
  • 45
    Nattinger AB, Kneusel RT, Hoffman RG, Gilligan MA. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst. 2000; 93: 13441346.
  • 46
    Velanovich V, Yood MU, Bawle U, et al. Racial differences in the presentation of surgical management of breast cancer. Surgery. 1999; 125: 375379.
  • 47
    Riley GF, Potosky AL, Klabunde CN, Warren JL. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. J Am Med Assoc. 1999; 281: 755756.
  • 48
    Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996; 88: 701703.
  • 49
    Krupat E, Irish JT, Kasten LE, et al. Patient assertiveness and physician decision-making among older breast cancer patients. Soc Sci Med. 1999; 49: 449457.
  • 50
    Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic and black women in the United States. J Natl Cancer Inst. 1994; 86: 705712.
  • 51
    Elmore JG, Moceri VM, Carter D, Larson EB. Breast carcinoma tumor characteristics in black and white women. Cancer. 1998; 83: 25092515.
  • 52
    Veronesi U, Luini A, Del Vecchio M,et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993; 328: 15871591.
  • 53
    Fisher B, Anderson S, Redmond C, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995; 333: 14561461.
  • 54
    Hayman JA, Fairclough DL, Harris JR, Weeks JC. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy following conservative surgery for early-stage breast cancer. J Clin Oncol. 1997; 15: 12521260.
  • 55
    Morrow M, Harris JR, Schnitt SJ. Local control following breast-conserving surgery for invasive cancer: results of clinical trials. J Natl Cancer Inst. 1995; 87: 16691673.
  • 56
    Pierce L, Fowble B, Solin LJ, Schultz DJ, Rosser C, Goodman RL. Conservative surgery and radiation therapy in black women with early stage breast cancer: patterns of failure and analysis of outcome. Cancer. 1992; 69: 28312841.
  • 57
    Martelli G, DePalo G, Rossi N, et al. Long-term follow-up of elderly patients with operable breast cancer treated with surgery without axillary dissection plus adjuvant tamoxifen. Br J Cancer. 1995; 72: 12511255.
  • 58
    Cancer and Leukemia Group B. Protocol no. 9343: tamoxifen vs radiotherapy and tamoxifen after breast conservation in the elderly with local disease. Washington DC: Department of Health and Human Services, 1999.
  • 59
    National Cancer Institute. The NCI strategic plan to reduce health disparities. Washington, DC: National Cancer Institute, 2000.
  • 60
    Virginia Association of Health Plans. The managed care marketplace. Alexandria, VA: Virginia Association of Health Plans, 2000.
  • 61
    Mark DH. race and the limits of administrative data. J Am Med Assoc. 2001; 285: 337338.
  • 62
    Robinson WS. Ecological correlations and the behavior of individuals. Am Sociol Rev. 1950; 15: 351357.
  • 63
    Freeman HP. The meaning of race in science — considerations for cancer research. Cancer. 1998; 82: 219225.